UBS reiterates buy rating on Sportradar stock amid favorable rights costs

UBS reiterated its buy rating and $29 price target on Sportradar (SRAD), citing effective management of sports rights costs and a strong balance sheet, while the stock trades near its 52-week high after a 121% one-year return. The analysis contrasts Sportradar's approach to rights acquisition with Genius Sports’ (GENI) recent NFL extension, which came at a significantly higher cost. Sportradar also reported strong Q1 earnings, with revenue of $311 million and adjusted EBITDA of $59 million, and maintained its fiscal year 2025 guidance, forecasting revenue of at least $1.273 billion and an adjusted EBITDA of $281 million.

Analysis

UBS maintained its buy rating and $29.00 price target on Sportradar Group AG (SRAD), highlighting the company's effective management of sports rights costs, with renewals secured at "low to mid single digit" increases, contrasting sharply with Genius Sports' (GENI) recent, more expensive NFL extension. This cost discipline, coupled with a balance sheet showing more cash than debt—a point also noted by InvestingPro analysis—supports Sportradar's financial sustainability, an area where Genius Sports has reportedly experienced negative net cash changes. The stock, trading at $25.14 and near its 52-week high, has delivered an impressive 121% return over the past year. Sportradar's strong operational momentum is further evidenced by its first-quarter results, which surpassed expectations with $311 million in revenue and $59 million in adjusted EBITDA, leading to a reiterated fiscal year 2025 guidance of at least $1.273 billion in revenue and $281 million in adjusted EBITDA. The recent acquisition of exclusive betting data rights for the FIFA Club World Cup 2025 and positive price target revisions from JPMorgan (to $26), Needham (to $28), and Benchmark (reiterated Buy, $30 target) underscore continued confidence, with the potential acquisition of IMG ARENA identified as a further growth catalyst.

Key Decisions for Investors

• Investors could consider the reaffirmed buy ratings and strong fundamentals, including effective cost management and robust earnings, as supportive of Sportradar's current valuation, despite its significant recent share price appreciation.
• The company's differentiated strategy in sports rights acquisition, particularly its ability to manage cost increases effectively compared to peers like Genius Sports, alongside a strong balance sheet, presents a key competitive advantage for sustained profitability and long-term growth.
• Monitor upcoming major league deal renewals, the execution on its fiscal year 2025 guidance, and the progress of any potential acquisitions, such as IMG ARENA, as these could serve as significant catalysts for future value creation and margin expansion.